Leveraging Multi‐Omics Approaches and Advanced Technologies to Unravel the Molecular Complexities, Modifiers, and Precision Medicine Strategies for Hemoglobin H Disease
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Akshata Pahelkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Precision Medicine, Genomics, alpha-Thalassemia, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Hemoglobin H (HbH) disease, a form of alpha‐thalassemia, poses significant clinical challenges due to its complex molecular underpinnings. It is characterized by reduced synthesis of the alpha‐globin chain. The integration of multi‐omics and precision medicine holds immense potential to comprehensively understand and capture interactions at the molecular and genetic levels. This review integrates current multi‐omics approaches and advanced technologies in HbH research. Furthermore, it delves into detailed pathophysiology and possible therapeutics in the upcoming future. We explore the role of genomics, transcriptomics, proteomics, and metabolomics studies, alongside bioinformatics tools and gene‐editing technologies like CRISPR/Cas9, to identify genetic modifiers, decipher molecular pathways, and discover therapeutic targets. Recent advancements are unveiling novel genetic and epigenetic modifiers impacting HbH disease severity, paving the way for personalized precision medicine interventions. The significance of multi‐omics research in unraveling the complexities of rare diseases like HbH is underscored, highlighting its potential to revolutionize clinical practice through precision medicine approaches. This paradigm shift can pave the way for a deeper understanding of HbH complexities and improved disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra, India.
- MES's H. K. College of Pharmacy, Mumbai, Maharashtra, India.
ORCID-Profile: Akshata Pahelkar
Zitieren
APA
Pahelkar, A., Sharma, D., Vohra, P., & Sawant, S. (2024). Leveraging Multi‐Omics Approaches and Advanced Technologies to Unravel the Molecular Complexities, Modifiers, and Precision Medicine Strategies for Hemoglobin H Disease. European Journal of Haematology. https://doi.org/10.1111/ejh.14319
Vancouver
Pahelkar A, Sharma D, Vohra P, Sawant S. Leveraging Multi‐Omics Approaches and Advanced Technologies to Unravel the Molecular Complexities, Modifiers, and Precision Medicine Strategies for Hemoglobin H Disease. European Journal of Haematology. 2024. doi:10.1111/ejh.14319
BibTeX
@article{Pahelkar2024,
author = {Pahelkar, Akshata and Sharma, Deep and Vohra, Payaam and Sawant, Sayli},
title = {Leveraging Multi‐Omics Approaches and Advanced Technologies to Unravel the Molecular Complexities, Modifiers, and Precision Medicine Strategies for Hemoglobin H Disease},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14319}
}
EUVIMED